Patents Examined by Kenneth Horlick
  • Patent number: 9586987
    Abstract: The present invention provides a primer set including primers that can be designed easily, with which an amplification distance can be shortened. Provided is a primer set for use in a method for isothermally amplifying a target nucleic acid sequence 4. The primer set includes a first primer 1F and a second primer 1R. The first primer 1F includes, on the 3? side thereof, a sequence (A?) that can hybridize to a sequence (A) on the 3? side of the target nucleic acid sequence. The second primer 1R includes, on the 3? side thereof, a sequence (B?) that can hybridize to a sequence (B) on the 3? side of either a strand extended from the first primer or a complementary strand of the target nucleic acid sequence 4. The first primer 1F and the second primer 1R include, on the 5? sides thereof, sequences (C) that are substantially identical to each other.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: March 7, 2017
    Assignee: Kabushiki Kaisha DNAFORM
    Inventors: Yoshihide Hayashizaki, Yasumasa Kimura, Kengo Usui, Yuki Tanaka, Yuki Kawai
  • Patent number: 9574233
    Abstract: The present invention relates to a method for the detection of nucleic acid synthesis and/or amplification, characterized in that the method includes adding at least one colorimetric metal indicator and at least one bland magnesium chelator to a reaction mixture for nucleic acid amplification. The present invention further relates to a kit for carrying out such a method and to the use thereof in the health, food and agricultural or veterinary fields.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: February 21, 2017
    Assignee: Genefast S.R.L.
    Inventors: Maria Elena Turba, Elisa Zambon
  • Patent number: 9546404
    Abstract: Described herein are methods, compositions and kits directed to the detection of gene dysregulations such as those arising from gene fusions and/or chromosomal abnormalities, e.g., translocations, insertions, inversions and deletions. Samples containing dysregulated gene(s) of interest may show independent expression patterns for the 5? and 3? regions of the gene. The methods, compositions and kits are useful for detecting mutations that cause the differential expression of a 5? portion of a target gene relative to the 3? region of the target gene.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: January 17, 2017
    Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
    Inventors: Heather R. Sanders, Maher Albitar, Aurelia Meloni-Ehrig
  • Patent number: 9540637
    Abstract: Provided herein are compositions, systems, methods, and kits for joining together the ends of one or more polynucleotides using at least one pair of blocking oligonucleotide adaptors. Blocking oligonucleotide adaptors can be used to reduce the formation of adaptor dimers or trimers (or higher-order concatemers) which can improve the yield of desirable polynucleotide-adaptor products in any recombinant nucleic acid workflow. Blocking oligonucleotide adaptors can comprise a double-stranded oligonucleotide adaptor (duplex) having an overhang cohesive portion that anneals with a blocking oligonucleotide which can be a separate single-stranded oligonucleotide. A blocking oligonucleotide, when annealed to an overhang portion, can prevent undesirable hybridization of the overhang portion to another nucleic acid, such as the overhang portion from another blocking oligonucleotide adaptor or a polynucleotide of interest.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: January 10, 2017
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Bin Li, Zhoutao Chen, Tanya Biorac, Melvin Shiwade Wei
  • Patent number: 9528146
    Abstract: This invention provides novel compositions and processes for analyte detection, quantification and amplification. Nucleic acid arrays and libraries of analytes are usefully incorporated into such compositions and processes. Universal detection elements, signaling entities and the like are employed to detect and if necessary or desirable, to quantify analytes. Amplification of target analytes are also provided by the compositions and processes of this invention.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: December 27, 2016
    Assignee: Enzo Life Sciences, Inc.
    Inventors: Elazar Rabbani, Jannis G. Stavrianopoulos, James J. Donegan, Jack Coleman
  • Patent number: 9528162
    Abstract: This invention relates to a rapid method for detection and characterization of STEC bacteria based on the presence of nucleic acid sequences, in particular, to a PCR-based method for detection, and to oligonucleotide molecules and reagents and kits useful therefore. This method is preferably employed to detect STEC bacteria in a food or water sample, such as a beef enrichment. The present invention further relates to isolated polynucleotides, replication compositions, kits, and reagent tablets for carrying out the method of the present invention.
    Type: Grant
    Filed: July 8, 2014
    Date of Patent: December 27, 2016
    Assignee: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: Stephen Varkey, Daniel R. DeMarco, Mark A. Jensen
  • Patent number: 9523121
    Abstract: Provided herein are methods and compositions for performing PCR with primers with blocked 3?-ends that are unblocked when these primers anneal to the template. The multiplexed PCR can be used as real-time qPCR, for end-point detection or as enrichment method for next generation sequencing (NGS). Also described herein are methods and compositions to improve sensitivity of mutation-specific PCR when targeting closely-spaced mutations.
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: December 20, 2016
    Assignee: Uni Taq Bio
    Inventors: Eugene Spier, Karl Guegler
  • Patent number: 9512488
    Abstract: One embodiment of the present invention provides a detection kit for detecting a chronic myelogenous leukemia (CML) gene expression, wherein the detection kit includes a primer set which is specifically bound to the CML gene; and a cleavable probe which is specifically bound to the inside of a CML gene amplification product which is amplified by the primer set. Another embodiment of the present invention provides a method of measuring the CML gene expression by using the detection kit according to one embodiment of the present invention. The method according to one embodiment of the present invention is used to efficiently detect a low CML gene expression for CML diagnosis and prognosis diagnosis.
    Type: Grant
    Filed: January 9, 2013
    Date of Patent: December 6, 2016
    Assignee: Samsung Life Public Welfare Foundation
    Inventors: Kwang Woo Kim, Jong Won Kim, Do Hyun Nam, Chang-Seok Ki
  • Patent number: 9512470
    Abstract: Detecting nucleic acid sequences in a sample, such as the detection of pathogenic organisms in clinical samples. More specifically, detecting an infection caused by a pathogenic organism such as a virus or a bacterium in a clinical specimen by means of amplifying and detecting specific nucleic acid sequences from said pathogenic organism. A multiplex assay with the possibility to determine about 30 different target nucleic acid sequences in a single one-tube assay combined with real-time probe detection.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: December 6, 2016
    Assignee: Pathofinder Holding B.V.
    Inventors: Martinus Gerardus Cecilia Maria Reijans, Gijs Josephus Henricus Dingemans, Augustinus Franciscus Maria Simons, Antonia Alberdina Theodora Petronella Brink
  • Patent number: 9506845
    Abstract: Methods, systems, and devices are described for multiple single-cell capturing and processing utilizing microfluidics. Tools and techniques are provided for capturing, partitioning, and/or manipulating individual cells from a larger population of cells along with generating genetic information and/or reactions related to each individual cell. Different capture configurations may be utilized to capture individual cells and then processing each individual cell in a multi-chamber reaction configuration. Some embodiments may provide for specific target amplification, whole genome amplification, whole transcriptome amplification, real-time PCR preparation, copy number variation, preamplification, mRNA sequencing, and/or haplotyping of the multiple individual cells that have been partitioned from the larger population of cells. Some embodiments may provide for other applications. Some embodiments may be configured for imaging the individual cells or associated reaction products as part of the processing.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: November 29, 2016
    Assignee: Fluidigm Corporation
    Inventors: Brian Fowler, Jake Kimball, Myo Thu Maung, Andrew May, Michael C. Norris, Dominique G. Toppani, Marc A. Unger, Jing Wang, Jason A. A. West
  • Patent number: 9487821
    Abstract: This invention provides novel compositions and processes for analyte detection, quantification and amplification. Nucleic acid arrays and libraries of analytes are usefully incorporated into such compositions and processes. Universal detection elements, signaling entities and the like are employed to detect and if necessary or desirable, to quantify analytes. Amplification of target analytes are also provided by the compositions and processes of this invention.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: November 8, 2016
    Assignee: Enzo Life Sciences, Inc.
    Inventors: Elazar Rabbani, Jannis G. Stavrianopoulos, James J. Donegan, Jack Coleman
  • Patent number: 9487834
    Abstract: Maize event HCEM485 is provided, in which plants comprising the event are tolerant to exposure to a glyphosate herbicide. Maize genomic polynucleotides flanking the insert DNA providing glyphosate tolerance are provided. The plant or part thereof having the event comprises a junction region of the insert DNA and maize plant genomic sequences. Methods and primers and probes to detect the presence of the event are provided, as well as kits which employ such primers and probes.
    Type: Grant
    Filed: April 18, 2014
    Date of Patent: November 8, 2016
    Assignee: Stive Seed Farm
    Inventors: Bruce Held, Harry Stine, Vaithilingam Sekar, Ryan E. Pesch, Jr., Angela R. Umthun, Kelley S. Muir, Jason D. Behn, Herbert Martin Wilson
  • Patent number: 9481872
    Abstract: The present invention provides thermostable enzymes, such as DNA polymerases and restriction endonucleases, that are substantially free from contamination with nucleic acids. The invention also provides methods for the production of these enzymes, and kits comprising these enzymes which may be used in amplifying or sequencing nucleic acid molecules, including through use of the polymerase chain reaction (PCR).
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: November 1, 2016
    Assignee: Life Technologies Corporation
    Inventors: Adam Goldstein, A. John Hughes
  • Patent number: 9469870
    Abstract: A method of monitoring amplification of a nucleic acid by providing a nucleic acid and an amplification mixture using the kit of isothermal reagents to a pH sensor or pH indicator, amplifying the nucleic acid using isothermal amplification, and detecting a change in pH due to the amplification using the pH sensor or pH indicator. The kit of reagents comprises a magnesium salt, a quaternary ammonium salt, and an alkali base.
    Type: Grant
    Filed: July 16, 2012
    Date of Patent: October 18, 2016
    Assignee: DNAE GROUP HOLDINGS LIMITED
    Inventors: Maurizio Lamura, Angel Chan-Ju Wang, Alpesh Patel
  • Patent number: 9458453
    Abstract: The presently disclosed subject matter relates to modified Kunkel mutagenesis methods that use a thermostable DNA polymerase and a thermostable DNA ligase.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: October 4, 2016
    Assignee: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Elad Firnberg, Marc Alan Ostermeier
  • Patent number: 9453265
    Abstract: The invention provides compositions and methods for the differential detection of high risk forms of HPV from a urine sample provided by a patient. Specifically, the invention provides primers and probes that specifically recognize and bind sequences within the E1 gene of HPV. Detection of high risk forms of HPV identifies individuals at risk of developing or in the early stages of cervical carcinoma.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: September 27, 2016
    Assignee: Trovagene, Inc.
    Inventors: Samuil R. Umansky, Hovsep S. Melkonyan, Zhenghan M. Xin
  • Patent number: 9441278
    Abstract: The invention discloses means and methods for genotyping an individual head of cattle. Individual's DNA is genotyped utilizing the herein defined PCR SNaP-shot protocol. The protocol comprises two PCR steps where the first step (PCR1) includes adding primers (SEQ ID No. 1-30) and/or primers extended at their 5? end with a common 10 base motif (ACGTTGGATG) to the PCR1 reaction. The second step (PCR2) includes adding extension primers (SEQ ID No. 31-45), and/or primers adjacent to corresponding specific SNPs. Further steps include producing amplicons from a PCR1 mixture comprising template DNA and the first primer set to yield PCR1 products, using PCR1 products as templates to a set of extension primers to yield PCR2 products. Size and color separation is achieved by adding tails of different lengths to the PCR2 primers. PCR2 products are separated and the results compared with SNP profiles from the databank to obtain matching.
    Type: Grant
    Filed: June 14, 2009
    Date of Patent: September 13, 2016
    Assignees: BACTOCHEM LTD., STATE OF ISRAEL, MINISTRY OF AGRICULTURE AND RURAL DEVELOPMENT, A.R.O.—VOLCANI CENTER
    Inventors: Aviv Cahana, Andrey Shirak, Baruch Karniol, Yitzchak Skalsky, Joel Ira Weller, Micha Ron, Eyal Seroussi
  • Patent number: 9434980
    Abstract: A method is disclosed for concentrating sample constituents and for multiplying nucleic acids from a biological sample which are containing in the sample constituents. The nucleic acids are amplified on the same filter on which the sample constituents are also separated off.
    Type: Grant
    Filed: October 27, 2011
    Date of Patent: September 6, 2016
    Assignee: ROBERT BOSCH GMBH
    Inventors: Peter Rothacher, Jan Weile, Susanne Muench, Martina Daub
  • Patent number: 9428802
    Abstract: Disclosed herein is a self-competitive primer for preferentially amplifying a sample nucleic acid based on whether a selected region thereof has a nucleotide variation, in comparison with a selected region of a reference nucleic acid. The self-competitive primer includes a 5?-competing domain and a 3?-elongating domain. Sequences of the 5?-competing domain and the 3?-elongating domain are complementary to a first region and a second region of the reference nucleic acid, respectively. The first region includes the selected region and at least one nucleotide residue immediately downstream of the selected region of the reference nucleic acid. The second region is located downstream of the selected region of the reference nucleic acid and does not comprise the selected region of the reference nucleic acid, and the first region and the second region overlap by at least one nucleotide.
    Type: Grant
    Filed: July 3, 2012
    Date of Patent: August 30, 2016
    Assignee: MACKAY MEMORIAL HOSPITAL
    Inventors: Jr-kai Huang, Chi-Kuan Chen, Tao-Yeuan Wang
  • Patent number: 9428812
    Abstract: Disclosed are methods and kits for detecting the presence of a cancer in a subject and assessing the efficacy of treatments for the same. The disclosed method use reverse transcription polymerase chain reaction (RT-PCR) techniques to detect the presence of point mutations, truncations, or fusions of anaplastic lymphoma kinase.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: August 30, 2016
    Assignee: Insight Genetics, Inc.
    Inventors: David R. Hout, Rachel Skelton, John Handshoe, Kasey Lawrence, Brock Schweitzer